sparfloxacin has been researched along with Atypical Mycobacterial Infection, Disseminated in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bentoucha, A; Dega, H; Grosset, J; Jarlier, V; Robert, J | 1 |
Bourgeois, P; Cambau, E; Desplaces, N; Dion, E; Dubourg, G; Koeger, AC; Robin, H; Roche, B; Rozenberg, S; Vergeron, H | 1 |
Andonegui, M; Martín-Casabona, N; Martínez, E; Royo, P | 1 |
Higashiyama, Y; Kohno, S; Maesaki, S; Miyazaki, Y; Tashiro, T; Tomiyama, Y; Tomono, K; Yong, B | 1 |
Adam, G; Haase, G; Riehl, J; Schmitt, H; Schnitzler, N; Sieberth, HG | 1 |
Kaur, D; Khuller, GK | 1 |
Everett, D; Gillespie, SH; Morrissey, I | 1 |
Kamisaka, K; Kawahara, S; Kibata, M; Konishi, H; Matsuyama, T; Mishima, Y; Shiomi, K; Tada, A; Takeuchi, M; Yoshimoto, S | 1 |
8 other study(ies) available for sparfloxacin and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Female; Fluoroquinolones; Foot; Mice; Mice, Inbred BALB C; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Rifampin; Skin Ulcer | 2002 |
Efficacy of combined clarithromycin and sparfloxacin therapy in a patient with discitis: due to Mycobacterium xenopi.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Discitis; Drug Therapy, Combination; Fluoroquinolones; Humans; Lumbar Vertebrae; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Quinolones; Sacrum | 1997 |
In vitro susceptibility of Mycobacterium kansasii to the difluorinated quinolone sparfloxacin using a broth microdilution and macrodilution MIC system.
Topics: Anti-Infective Agents; Antitubercular Agents; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii | 1999 |
[The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
Topics: Aged; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Pneumonia, Bacterial; Treatment Outcome | 1999 |
Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Fluoroquinolones; Humans; Killer Cells, Natural; Lung; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifabutin; Treatment Outcome; Tuberculosis, Pulmonary | 1999 |
In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Colony Count, Microbial; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Mycobacterium tuberculosis; Tuberculosis | 2001 |
A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Models, Biological; Moxifloxacin; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Ofloxacin; Quinolines | 2001 |
[A case of pulmonary atypical mycobacteriosis complicated with aplastic anemia, treated with surgical resection and postoperative sparfloxacin].
Topics: Anemia, Aplastic; Anti-Infective Agents; Antitubercular Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Fluoroquinolones; Humans; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonectomy; Quinolones; Tuberculosis, Pulmonary | 1992 |